We compared the dietary intake of participants with peripheral artery disease (PAD) and claudication with diet recommendations of the National Cholesterol Education Program (NCEP) and dietary reference intake values recommended by the Institute of Medicine (IOM) of the National Academy of Sciences. Forty-six participants consumed a mean macronutrient composition of 17% protein, 51% carbohydrate, and 30% fat. Compared to the NCEP and IOM recommendations, few participants met the recommended daily intake for sodium (0%), vitamin E (0%), folate (13%), saturated fat (20%), fiber (26%), and cholesterol (39%). Participants with PAD and claudication have poor nutrition, with diets particularly high in saturated fat, sodium, and cholesterol, and low in fiber, vitamin E, and folate intakes. Participants should be encouraged to reduce consumption of dietary fat, saturated fat, cholesterol, and sodium and to increase fiber and vitamin intakes to meet recommendations of the NCEP and IOM.
Introduction
Claudication is a symptom of peripheral arterial disease (PAD) and is associated with elevated rates of mortality [1] [2] [3] [4] and morbidity. 5 Claudication afflicts 5% of the US population older than 55 years of age 6 and occurs during ambulation when the peripheral circulation is inadequate to meet the metabolic requirement of the active leg musculature. Thus, intermittent claudication impairs ambulation 7, 8 and reduces daily physical activity. 9 Participants with PAD and claudication not only have high atherosclerotic burden, they also have numerous cardiovascular and metabolic comorbid conditions including dyslipidemia, hypertension, diabetes, smoking, obesity, abdominal obesity, and metabolic syndrome. [10] [11] [12] [13] [14] [15] Despite the impact that diet has on these cardiovascular and metabolic risk factors, 16, 17 little is known about the dietary intakes of participants with claudication. General dietary recommendations for those with cardiovascular disease typically include dietary intakes high in fruits, vegetables, and grain and low in fat, saturated fat, cholesterol, and sodium. 18 In addition to the long-term detrimental influence that a high-fat diet has on cardiovascular and metabolic comorbid conditions, consumption of a high-fat meal acutely impairs endothelial function. [19] [20] [21] This finding suggests that high dietary fat intake by participants with PAD and claudication may further impair an already compromised peripheral circulation to the lower extremities and worsen walking performance.
The purposes of this study are (a) to compare the dietary intakes of participants with PAD and claudication with diet recommendations of the National Cholesterol Education Program (NCEP) [22] [23] [24] and dietary reference intake values recommended by the Institute of Medicine (IOM) of the National Academy of Sciences 25 and (b) to determine whether the dietary intake of fat negatively affects vascular function and ambulatory function. The hypotheses are that participants with PAD consume a diet that exceeds the daily recommendations of fat, saturated fat, and cholesterol and that dietary fat and cholesterol impair vascular and ambulatory function.
Methods Participants
Recruitment. Participants were studied at the Geriatrics, Research, Education and Clinical Center, Maryland Veterans Affairs Health Care System (MVAHCS) at Baltimore. Participants were recruited from the Vascular Clinic in the Baltimore MVAHCS. The procedures used in this study were approved by the Institutional Review Boards at the University of Maryland and the MVAHCS at Baltimore. Written informed consent was obtained from each participant prior to investigation.
Screening. Participants with claudication secondary to vascular insufficiency were included in this study if they met the following criteria: (a) a history of claudication, (b) ambulation during a graded treadmill test limited by claudication, 7 and (c) an ankleÀbrachial index (ABI) 0.90 at rest, 26 or an ABI 0.73 after a treadmill exercise test in the symptomatic leg. 27 Participants were excluded from this study for the following conditions: (a) absence of PAD (ABI >0.90 at rest and >0.73 after exercise), 26,27 (b) inability to obtain an ABI measure due to noncompressible vessels, (c) asymptomatic PAD, (d) use of medications indicated for the treatment of intermittent claudication (cilostazol and pentoxifylline), (e) exercise tolerance limited by factors other than leg pain (eg, severe coronary artery disease, dyspnea, poorly controlled blood pressure), and (f) active cancer, renal disease, or liver disease. A total of 46 participants with claudication were deemed eligible for this investigation.
Measurements
Medical history, physical examination, and anthropometry. Demographic information, height, weight, body mass index (BMI), waist and hip circumferences, 28 cardiovascular risk factors, comorbid conditions, claudication history, blood samples, and a list of current medications were obtained from a medical history and physical examination at the beginning of the study.
Treadmill Test
Claudication times and peak oxygen uptake. Participants performed a progressive, graded treadmill protocol to determine study eligibility, as well as to obtain outcome measures related to peak exercise performance. 7 The claudication onset time (COT), defined as the walking time at which the patient first experienced pain, and the peak walking time (PWT), defined as the time at which ambulation could not continue due to maximal pain, were both recorded to quantify the severity of claudication. Peak oxygen uptake was measured by oxygen uptake obtained during the peak exercise work load with a Medical Graphics VO2000 metabolic system (Medical Graphics Inc, St Paul, Minnesota). Using these procedures, the testÀretest intra-class reliability coefficient is R ¼ .89 for COT, 7 R ¼ .93 for PWT, 7 and R ¼ .88 for peak oxygen uptake. 29 ABI and ischemic window. As previously described, ABI measures were obtained from the more severely diseased lower extremity before and 1, 3, 5, and 7 minutes after the treadmill test. 7, 30 The reduction in ankle systolic blood pressure after treadmill exercise from the resting baseline value was quantified by calculating the area under the curve, referred to as the ischemic window. 31 Because the ischemic window is a function of both PAD severity and the amount of exercise performed, the ischemic window was normalized per meter walked.
Dietary intake. Participants were given detailed verbal and written instructions to record all foods and beverages consumed for 7 consecutive days. Additionally, participants were provided food scales to weigh food portions for more accurate completion of the 7-day food record. On returning the dietary records, data were reviewed with the participants to better ensure completeness, preparation methods, and food description. Dietary records were analyzed by a registered dietitian using the NUTRITIONIST IV software program (Silverton, Oregon). 32 
Statistical Analyses
Descriptive statistics were calculated on clinical characteristics, exercise measures, and dietary measures of participants with PAD and claudication. Primary outcome variables include COT, PWT, and ischemic window. Partial Spearman correlation coefficients and their significance were determined for our primary outcome variables and dietary measures after adjusting for total caloric intake. All analyses were performed with a 2tailed significance level of .05. Analyses were conducted using SAS version 9.1 (Cary, North Carolina).
Results
The clinical characteristics of the participants with claudication are shown in Table 1 . The group consisted of a mix of older, overweight Caucasian and African American men. Cardiovascular risk factors were highly prevalent in the group, particularly hypertension, dyslipidemia, metabolic syndrome, and diabetes. Exercise performance measures of the participants are shown in Table 2 . COT and PWT occurred approximately 2.7 and 6.7 minutes during the treadmill test, and peak oxygen uptake and ischemic window values are typical for those with claudication. 11 The dietary measures of the participants with claudication are shown in Table 3 . On average, the participants consumed fewer than the daily reference value of 2000 kcals/d for men 51 years of age and older, 25 and their mean macronutrient composition consisted of 17% protein, 51% carbohydrate, and 30% fat. Compared to the NCEP and IOM recommendations, few participants met the recommended daily intakes for sodium (0%), vitamin E (0%), folate (13%), saturated fat (20%), fiber (26%), and cholesterol (39%).
The correlation coefficients between macronutrient measures of dietary intake and exercise performance measures are shown in Table 4 . After adjustment for total caloric intake, mono-unsaturated fat intake was negatively correlated with PWT (P < .05) and positively correlated with ischemic window (P < .01), and fiber intake was negatively correlated with COT (P < .05). During a follow-up analysis, we examined whether smoking status had an influence on dietary intake. Participants who currently smoked (n ¼ 15) had a lower intake of carbohydrate (209 + 51 vs 262 + 64 g/d; P ¼ .008), vitamin B6 (1.3 + 0.6 vs 1.8 + 0.6 mg/d; P ¼ .011), and fiber (11.3 + 7.0 vs 16.1 + 7.9 g/d; P ¼ .051) than nonsmokers (n ¼ 31). None of the other dietary variables were influenced by smoking status.
Discussion
The novel findings of this study were that none of the participants met the daily IOM recommendation for sodium consumption, and 80% exceeded the NCEP recommendation for saturated fat intake. Both dyslipidemia and hypertension are risk factors for the development of PAD, 13 symptomatic PAD, 15 and are highly prevalent comorbid conditions in participants with claudication. [10] [11] [12] 14 Although medical management of dyslipidemia and hypertension can reduce cardiovascular risk, participants with PAD are typically undertreated compared with those with coronary artery disease. 33 The high dietary intake of saturated fat, cholesterol, and sodium partially counteract the beneficial influences of pharmacologic therapy, if administered at all. Thus, participants with PAD and claudication need to be better informed and encouraged to follow the dietary guidelines of consuming a diet low in fat, saturated fat, cholesterol, and sodium to reduce risk of subsequent cardiovascular outcomes. Compliance with dietary therapy is enhanced with counseling from a registered dietitian to provide an individualized, aggressive diet modification. 34 Another key finding in the current investigation was that very few participants with PAD and claudication, particularly those who smoke, met the daily recommendation for dietary fiber. This indicates that the participants had diets low in whole grains, fruits, vegetables, and legumes. Fiber may be beneficial in reducing inflammation, as there is a strong relationship between increased fiber intake and lower C-reactive protein levels. 35 Furthermore, dietary fiber may have a protective effect against developing PAD, as a positive association between cereal fiber and ABI was found in the Edinburgh Artery study, 36 the Health Professional's Follow-up study, 37 and a recent report examining data from the National Health and Nutrition Examination Survey. 38 The benefit of dietary fiber is dose dependent, as the risk of PAD decreased with each quartile increase in fiber intake. 38 Thus, participants with PAD and claudication may experience some cardiovascular benefits by increasing dietary fiber intake, possibly manifest as reduced inflammation and improved macrovasculature and microvascular function. The potential benefits of increasing dietary fiber intake may be magnified in participants who smoke.
The consumption of mono-unsaturated fat was negatively associated with PWT and was positively associated with the ischemic window. These data indicate that participants with higher intake of mono-unsaturated fat had impaired ambulatory and vascular function during a standardized exercise test. The dietary intake of saturated fat and cholesterol showed the same trends, although they did not reach statistical significance. The correlation coefficients between mono-unsaturated fat and PWT and ischemic window supports our hypothesis that dietary fat impairs exercise performance and suggests that monounsaturated fat may have a negative influence on endothelial function. [19] [20] [21] However, it is surprising that mono-unsaturated fat was more predictive than saturated fat. Our results do not support a previous randomized trial, which found that dietary supplementation, which included mono-unsaturated fat, increased COT, and ABI. 39 Additionally, we found a negative correlation between dietary fiber and COT. Given that nearly all of the participants had very lower fiber intakes, it is difficult to interpret this association.
There are several limitations to this study. The sample size is small and the results are generalizable to participants with PAD and claudication during a standardized treadmill test. Thus, the current findings cannot be generalized to participants with asymptomatic PAD or to those who are limited in their exercise performance by other significant comorbid conditions. Another limitation is that all of the participants were veteran men. Despite this select sample of PAD participants, African Americans are well represented, and typical risk factors for PAD such as smoking, diabetes, hypertension, dyslipidemia, and obesity are highly prevalent. Thus, in participants with PAD and claudication, the findings of the current study are generalizable to the large proportion with numerous comorbid conditions. Another limitation is that dietary intake was measured with a 7-day food record and is subject to errors of selfreport. Finally, there are limitations associated with the cross-sectional design of the study. The correlations calculated between dietary measures and exercise performance measures do not allow causality to be established, as it is possible that diet influences exercise performance or vice versa.
Conclusion and Clinical Significance
The main findings of this investigation were that (a) participants with PAD and claudication had dietary intake high in saturated fat, sodium, and cholesterol and low in fiber, vitamin E, and folate intakes, and (b) high intake of mono-unsaturated fat was associated with low PWT and high ischemic window. We conclude that participants with PAD and claudication have poor nutrition and that dietary intake of mono-unsaturated fat was associated with impaired ambulatory and vascular function. The clinical significance is that participants should be encouraged to reduce their consumption of dietary fat and sodium and to increase fiber, vitamin E, and folate intake to meet NCEP and IOM recommendations. Along with appropriate medical management and advice to walk and avoid smoking, these dietary modifications, preferably with counseling from a registered dietitian, should also be viewed as a key component to reduce cardiovascular risk and enhance ambulatory and vascular function in participants with PAD and claudication.
